Spring Creek Capital’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Spring Creek Capital’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-800,000	Closed	-$7.81M	–	465
2022 Q1	$7.81M	Hold	800,000	–	–	0.31%	47
2021 Q4	$7.8M	Hold	800,000	–	–	0.3%	46
2021 Q3	$7.82M	Buy	+800,000	New	+$7.81M	0.38%	43

Other funds holding ORIA

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

ACM

Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Spring Creek Capital's ORIA Position: Q2 2022 in Review

Spring Creek Capital sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2022, closing a stake of 800,000 shares — an estimated $7.81M sold.

Spring Creek Capital first reported a position in ORIA in Q3 2021 and held it in 3 quarters. The position peaked at $7.82M in Q3 2021. 48 funds tracked by Wall St. Rank hold ORIA as of Q2 2022.

Spring Creek Capital reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2022 after selling out during the quarter.
Spring Creek Capital sold 800,000 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2022, an estimated $7.81M.
Spring Creek Capital first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2021 and held it in 3 quarters.
Spring Creek Capital's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $7.82M in Q3 2021.
48 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2022.

Based on Spring Creek Capital's 13F filing for Q2 2022.